Search Results
Results found for "Helen Su"
- Past Events by Dr. GPCR Ecosystem
From immersive workshops and high-energy summits to intimate retreats and virtual conferences, each event Advancing GPCR Drug Discovery Through Collaboration Discovery On Target 2024 GPCR targeted drug discovery Summit 2024 GPCR targeted drug discovery Summit 2023 The Dr. GPCR Podcast GPCR targeted drug discovery Summit 2022 Dr.
- Our History | Dr. GPCR Ecosystem
GPCR has united researchers across disciplines and continents through conversations, summits, and shared First Summit Sep 14–18, 2020 — The inaugural Dr. Lefkowitz , 2012 Nobel Laureate in Chemistry. 2nd Annual Summit Sep 13–19, 2021 — The 2nd Dr. Mar 2022 — Media Partner at GPCR Targeted Drug Discovery Summit . Community Engagement Mar 2024 — Media Partner at 3rd GPCR Targeted Drug Discovery Summit .
- Dr. Michael Feigin | Dr. GPCR Ecosystem
Craig Malbon at SUNY Stony Brook studying the role of G-protein coupled receptors (GPCRs) and their regulators GPCR AI Summary AI-generated content may be inaccurate or misleading. Always check for accuracy. Summary Science Roles and Resilience Yamina and Mike had a conversation about their roles and experiences They also discussed the challenges of the two-body problem, where both partners need to find suitable Yamina proposed further exploration of dosage and length of treatment in a mouse model and suggested
- Foundry for GPCR Organizations | Dr. GPCR Ecosystem
Expert support, trusted CROs, and ready-to-use tools to accelerate GPCR drug discovery, reduce risk, Book a Strategy Call → Our Core Support Areas Discovery Consulting & Strategy Expert guidance to de-risk
- GPCR University Group Package | Dr. GPCR Ecosystem
If fewer than five members are submitted: • Memberships won’t be activated. • You’ll receive a 50% refund to cover processing costs. 👉 Please double-check your team list before submitting to avoid delays. GPCR Ecosystem account . 2 — Submit Your Team Details Provide names, emails, and organization information
- Dr. GPCR Ecosystem | Connect, Collaborate, and Innovate
. 🤝 Support the Mission
- FAQ | Dr. GPCR Ecosystem
These webinars are designed for scientists who want deep, data-driven discussion rather than surface-level Are these GPCR webinars suitable for industry scientists? Yes. These webinars are designed to support ongoing scientific development in GPCR pharmacology and drug discovery
- YC-VC Insights | Dr. GPCR Ecosystem
That's where I come in : to pressure-test the science, align the strategy, and make sure every experiment Let’s talk about how I support GPCR discovery, pharmacology strategy, and cross-functional execution
- Who We Are | Dr. GPCR Ecosystem
We designed the Ecosystem to support your work —no matter where you are in your GPCR journey. Episode Launched our podcast to share expert insights with the scientific community. 2021 2nd Annual Summit
- Revvity | Dr. GPCR Ecosystem
This technology supports robust analysis even at low endogenous receptor expression levels. Suitable for basal/constitutive and agonist-induced GPCR internalization Compatible with TRF plate readers address unmodified receptors in primary cells View Product The Fab Anti-Mouse IgG2 Eu-conjugate is suited ✅ Comprehensive validation: validated for GPCRs, but also antibodies and ADCs. ✅ Versatility across suspension Revvity offers a comprehensive reagent portfolio to match that complexity—supporting every stage of the
- Receptor Signaling Bias: A Valuable and Accessible Property of New Drug Candidates | Dr. GPCR Ecosystem
cell-based assays spanning basic research through therapeutic discovery, optimization, and regulatory submission
- Yamina's Corner | Dr. GPCR Ecosystem
chaos into clarity—Yamina’s Corner offers expert GPCR strategy, CRO guidance, and tailored scientific support Book My Consultation Critical Bottlenecks in Your GPCR Pipeline ❌ Overwhelming pharmacology Data ❌ Suboptimal Partnerships ❌ Stalled Pipeline Progression ❌ Uncertainty in GPCR Investments Advisory Focus Areas Expert support Power Discovery How We Work: Your Path to GPCR Success 1 Initial Strategic Alignment We begin with a Let’s talk about how I support GPCR discovery, pharmacology strategy, and cross-functional execution
- GPCR University Group Package | Dr. GPCR Ecosystem
We want to support academic labs with the same high-quality tools, courses, and insights used by leading covers: Eligibility guidelines Teaching formats & examples Instructor expectations Course creation support
- Dr. Alix A. J. Rouault | Dr. GPCR Ecosystem
Further, I applied to create a scientific session at the American Physiology Summit (APS) 2024 dedicated We were pleasantly surprised by the interest generated by our scientific session, Dr. I want to connect more trainees with diverse career resources to support professional decision-making I am hopeful that my efforts to support the professional opportunities of my peers, in combination with
- Ross Cheloha: Nanobody-GPCR Conjugates and the Engineering of Receptor Selectivity | Dr. GPCR Ecosystem
And can selectivity for one receptor subtype be engineered without redesigning the ligand from scratch 10,000-fold, and how the selectivity of the nanobody - not the ligand - is what engineers receptor subtype have been using this distinction all along: two natural ligands for the same receptor already show subtly The working model is that the nanobody anchors the conjugate at the receptor surface, positioning the Attaching a short PTH fragment to a PTHR1-selective nanobody produces a ligand selective for that subtype
- Fiona Marshall: Three Decades Inside GPCR Drug Discovery | Dr. GPCR Ecosystem
Pathway Dials The promise of biased ligands — pulling one signaling arm while sparing another — only survives
- Alexander Hauser: GPCR Pharmacogenomics and Precision Psychiatry | Dr. GPCR Ecosystem
culture makes it structurally possible 31:45 - Mentoring philosophy - teaching through mistakes and sustaining
- Joseph Kim: Structural Biology and Drug Discovery at GPCRs | Dr. GPCR Ecosystem
Supportive collaborative environments accelerate scientific progress. Joseph Kim: Sure. There’s evidence suggesting that it plays roles in feeding behavior and analgesia , somewhat similar Some studies also suggest that the galanin receptors may interact with the μ-opioid receptor. lab where people were supportive and willing to teach.
- Terry Hebert: How Cellular Background and Localization Influence GPCR Function | Dr. GPCR Ecosystem
The discussion also explores GPCRs beyond the cell surface — including caged ligands designed to drug Regulators — The observation that G-proteins enter the nucleus and interact with transcriptional machinery, suggesting functions entirely distinct from canonical cell-surface signaling. Drugging GPCRs on the Nuclear Membrane GPCRs are not confined to the cell surface. Dr.
- Chloe Hicks | Dr. GPCR Ecosystem
These previous endeavors involved exploring the effect of subcellular location on the signaling profile
- Exploring Career Paths in GPCR Research with Dr. Jacek Mokrosiński | Dr. GPCR Ecosystem
He then moved to Denmark, where he trained at the University of Copenhagen under supervision of Professor GPCR AI Summary AI-generated content may be inaccurate or misleading. Always check for accuracy. Summary Embracing Cultural Differences and Collaboration Yamina and Jacek shared their experiences with He also underscored the role of the people around him, expressing gratitude for their guidance and support
- Dr. Yamina Berchiche | Dr. GPCR Ecosystem
Ecosystem, with the goal is to bring together GPCR scientists, biotech, and pharma leaders as well as suppliers
- Brian Arey - Part 2: GPCR Drug Discovery and the Science Nobody Publishes | Dr. GPCR Ecosystem
Target validation programs are built, defended, and sometimes cancelled before a single paper is submitted disease biology, with contributions to multiple clinical programs including preclinical models that supported describes the experience with something between resignation and dry satisfaction: he knew, the data supported he has generated throughout his career originated in pattern recognition and intuition, before any supporting He describes this as the only environment in which people are willing to surface the unconventional idea
- GPCR location matters with Dr. Gabriele Kockelkoren | Dr. GPCR Ecosystem
Technical University of Delft in The Netherlands, I pursued a PhD at the University of Copenhagen under the supervision
- Annette Gilchrist: Native Cell Systems, Biased Agonism, and the Pharmacogenomics Gap | Dr. GPCR Ecosystem
field had not documented before: constitutive beta-arrestin activity at a wild-type FFA2 receptor, suppressible For Gilchrist, the result was not a surprise so much as a confirmation - if you look in the right system She also brings early industry experience from Pfizer, where her first sustained encounter with pharmacology Antibody therapeutics for GPCRs: the pipeline argument Biologics have a substantially higher success of drugging a receptor without knowing what activates it naturally, and getting therapeutic results, suggests
- Custom Molecules, Fluorescent Probes: When Chemists Think Like Biologists with Dr. Maria Majellaro from Celtarys | Dr. GPCR Ecosystem
I wasn’t sure at first, but I realized I could do this too.” — Maria Majellaro Her decisions, often made That changed with support from Galicia’s robust biotech network, and the company quickly defined its The Complexity Behind Every “Successful” Probe Maria is candid about the technical challenges behind Their work directly supports the tool-building mission that aligns with the Dr. GPCR ecosystem. To date, she has successfully led seven funded projects.
- Brian Bender: Computational Probes for Orphan GPCR | Dr. GPCR Ecosystem
Back to podcast list Strategic Partner(s) Brian Bender: Computational Probes for Orphan GPCR The GPCR superfamily Finding an endogenous agonist - when one is even known - is rarely sufficient: a large peptide or lipidated for pan-GPCR chemical probe discovery The orphan receptor problem - why endogenous agonists are not sufficient it became a forced pivot into computation at precisely the moment his modeling skills were becoming sufficient - produced an unexpected result: structural and sequence patterns connecting receptors across GPCR subfamilies
- GPCRs and the Science Behind Pain and Recovery with Dr. Alex Serafini | Dr. GPCR Ecosystem
his trajectory took a sharp turn after struggling with unresolved, chronic pain following repeated surgeries
- Arun Shukla: How Two Arrestins Regulate 800 GPCRs | Dr. GPCR Ecosystem
How two structurally similar proteins orchestrate such functional diversity across an entire receptor superfamily Biased agonism is harder than the opioid story suggested The neat bifurcation between G-protein and beta-arrestin signaling that drove early opioid receptor drug design has not held up cleanly in subsequent studies Shukla wasn't sure research would be his career. "I was not, to be honest, sure if research was what I wanted to take up as a career.
- Dr. Ralf Jockers | Dr. GPCR Ecosystem
International Research Network (IRN) i-GPCRnet of the CNRS, is chair of IUPHAR « Melatonin receptor » sub-committee




















